Drug Type Molecular glue |
Synonyms RCZY690, ZYSM003 |
Target |
Action inhibitors |
Mechanism RAS inhibitors(RAS type GTPase family inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | IND Application | China | 17 Jul 2026 | |
| Colorectal Cancer | Preclinical | China | 27 Apr 2025 | |
| Non-Small Cell Lung Cancer | Preclinical | China | 27 Apr 2025 | |
| Pancreatic Ductal Adenocarcinoma | Preclinical | China | 27 Apr 2025 |





